Bristol-Myers Squibb: Francis Cuss, MB BChir, FRCP
 
Leadership
Francis Cuss, M.D., F.R.C.P.
Francis Cuss, MB BChir, FRCP
Executive Vice President and
Chief Scientific Officer, R&D

Francis Cuss has served as Chief Scientific Officer since July 2013, and has been a member of the company’s Senior Management Team since 2010.

“Today we can see extraordinary new possibilities for addressing unmet medical need,” said Cuss. “And our R&D organization is well positioned to deliver on these opportunities.”

Francis is a physician with a background in general and academic medicine and broad experience in both pharmaceutical research and development. He joined Bristol-Myers Squibb in 2003 as senior vice president, Drug Discovery, took over additional responsibility for the discovery and exploratory development of potential new medicines in May 2006, and for all Research functions in 2010.

Prior to joining the company, he spent 14 years at Schering-Plough and three years at Glaxo, where his career included leadership roles in discovery, clinical research and medical affairs in the U.S. and Europe. Prior to joining the pharmaceutical industry, Francis was a practicing physician with a specialization in pulmonary medicine. He has also held several academic appointments, most recently as adjunct associate professor at Jefferson Medical College in Philadelphia, PA.

Francis received his medical training in the United Kingdom. He holds medical degrees from Cambridge University, U.K. and is a fellow of the Royal College of Physicians and the Faculty of Pharmaceutical Medicine. He has published numerous articles and book chapters on topics of medical interest.

July 2013

 
 
 
 


You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.
You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.